MDC Stock Overview
Mediclinic International plc, together with its subsidiaries, operates private hospitals. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Mediclinic International plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£5.01 |
| 52 Week High | UK£5.14 |
| 52 Week Low | UK£3.86 |
| Beta | 0.42 |
| 1 Month Change | 0.44% |
| 3 Month Change | 0.56% |
| 1 Year Change | 25.38% |
| 3 Year Change | 68.12% |
| 5 Year Change | -14.94% |
| Change since IPO | -43.77% |
Recent News & Updates
Recent updates
Here's Why We Think Mediclinic International (LON:MDC) Might Deserve Your Attention Today
Jul 26
Estimating The Intrinsic Value Of Mediclinic International plc (LON:MDC)
Jul 12Here's Why Mediclinic International (LON:MDC) Can Manage Its Debt Responsibly
Jun 28Are Investors Undervaluing Mediclinic International plc (LON:MDC) By 50%?
Apr 08Is Mediclinic International (LON:MDC) Using Too Much Debt?
Mar 09Mediclinic International (LON:MDC) Takes On Some Risk With Its Use Of Debt
Nov 20Is There An Opportunity With Mediclinic International plc's (LON:MDC) 25% Undervaluation?
Sep 08Is Mediclinic International (LON:MDC) Using Too Much Debt?
Jun 21Does This Valuation Of Mediclinic International plc (LON:MDC) Imply Investors Are Overpaying?
May 26If You Had Bought Mediclinic International's (LON:MDC) Shares Five Years Ago You Would Be Down 63%
Mar 17What Kind Of Shareholders Hold The Majority In Mediclinic International plc's (LON:MDC) Shares?
Feb 26Mediclinic International plc (LON:MDC) Could Be Less Than A Year Away From Profitability
Feb 11Have Mediclinic International plc (LON:MDC) Insiders Been Selling Their Stock?
Jan 27
Estimating The Fair Value Of Mediclinic International plc (LON:MDC)
Jan 18These 4 Measures Indicate That Mediclinic International (LON:MDC) Is Using Debt Extensively
Jan 01A Look At Mediclinic International's (LON:MDC) Share Price Returns
Dec 17Our View On Mediclinic International's (LON:MDC) CEO Pay
Dec 02Shareholder Returns
| MDC | GB Healthcare | GB Market | |
|---|---|---|---|
| 7D | 0.1% | -0.7% | -1.5% |
| 1Y | 25.4% | -24.7% | 3.5% |
Return vs Industry: MDC exceeded the UK Healthcare industry which returned 5.3% over the past year.
Return vs Market: MDC exceeded the UK Market which returned -2.5% over the past year.
Price Volatility
| MDC volatility | |
|---|---|
| MDC Average Weekly Movement | 0.5% |
| Healthcare Industry Average Movement | 5.0% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 10.6% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: MDC has not had significant price volatility in the past 3 months.
Volatility Over Time: MDC's weekly volatility (1%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | 33,683 | Ronnie van der Merwe | www.mediclinic.com |
Mediclinic International plc, together with its subsidiaries, operates private hospitals. The company offers specialist-orientated and multidisciplinary healthcare services under the Mediclinic and Hirslanden brand names. It operates 74 hospitals, 20 day case clinics, 22 outpatient clinics, 5 subacute hospitals, 2 mental health facilities, and 453 theatres with approximately 11,538 inpatient beds in Switzerland, South Africa, Namibia, the Middle East, and the United Kingdom.
Mediclinic International plc Fundamentals Summary
| MDC fundamental statistics | |
|---|---|
| Market cap | UK£3.69b |
| Earnings (TTM) | UK£169.00m |
| Revenue (TTM) | UK£3.38b |
21.9x
P/E Ratio1.1x
P/S RatioIs MDC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MDC income statement (TTM) | |
|---|---|
| Revenue | UK£3.38b |
| Cost of Revenue | UK£2.66b |
| Gross Profit | UK£728.00m |
| Other Expenses | UK£559.00m |
| Earnings | UK£169.00m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.23 |
| Gross Margin | 21.52% |
| Net Profit Margin | 5.00% |
| Debt/Equity Ratio | 54.1% |
How did MDC perform over the long term?
See historical performance and comparisonDividends
0.6%
Current Dividend Yield13%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/05/31 23:24 |
| End of Day Share Price | 2023/05/26 00:00 |
| Earnings | 2022/09/30 |
| Annual Earnings | 2022/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Mediclinic International plc is covered by 18 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Sean Ungerer | Arqaam Capital Research Offshore S.A.L. |
| Simon Mather | Barclays |
| Victoria Lambert | Berenberg |